INS and metabolic dysfunction-associated steatotic liver disease: In patients with type 2 diabetes mellitus and non-alcoholic fatty liver disease, the converging effects of insulin resistance, chronic inflammation, and hepatic steatosis undermine renal function and the body’s calcium metabolism, facilitating the emergence of calcium deposits in wrong places such as heart valves.